Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引：0
|
作者：
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构：
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65041-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A283 / A284
页数：2
相关论文
共 50 条
  • [21] Cost analysis of long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS).
    Gupta, P
    LeRoy, SC
    Bateman, A
    Morrison, VA
    BLOOD, 1998, 92 (10) : 421A - 421A
  • [22] Thalidomide produces transfusion independence in patients with long-standing refractory anemias and myelodysplastic syndromes (MDS).
    Raza, A
    Lisak, L
    Andrews, C
    Little, L
    Muzammil, M
    Alvi, S
    Mazzoran, L
    Zorat, F
    Akber, A
    Ekbal, M
    Razvi, S
    Venugopal, P
    BLOOD, 1999, 94 (10) : 661A - 661A
  • [23] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    CALAVREZOS, A
    SEEGER, D
    KUSE, R
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
  • [24] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [25] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [26] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [27] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [28] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [29] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [30] Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications
    Gupta, P
    LeRoy, SC
    Luikart, SD
    Bateman, A
    Morrison, VA
    LEUKEMIA RESEARCH, 1999, 23 (10) : 953 - 959
12345